LIP
MRSN

Lighthouse Investment Partners’s Mersana Therapeutics MRSN Stock Holding History

Lighthouse Investment Partners’s Portfolio MRSN Stock Details MRSN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-5,181
Closed -$580K – 496
2024
Q1 		$580K Buy
+5,181
New +$515K 0.03% 319

Other funds holding MRSN

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Lighthouse Investment Partners's MRSN Position: Q2 2024 in Review

Lighthouse Investment Partners sold out of Mersana Therapeutics (MRSN) in Q2 2024, closing a stake of 5,181 shares — an estimated $580K sold.

Lighthouse Investment Partners first reported a position in MRSN in Q1 2024 and held it in 1 quarter. The position peaked at $580K in Q1 2024. 120 funds tracked by Wall St. Rank hold MRSN as of Q2 2024.

  • Lighthouse Investment Partners reported no remaining Mersana Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Lighthouse Investment Partners sold 5,181 Mersana Therapeutics shares in Q2 2024, an estimated $580K.
  • Lighthouse Investment Partners first reported a position in Mersana Therapeutics in Q1 2024 and held it in 1 quarter.
  • Lighthouse Investment Partners's Mersana Therapeutics position peaked at $580K in Q1 2024.
  • 120 funds tracked by Wall St. Rank held Mersana Therapeutics as of Q2 2024.

Based on Lighthouse Investment Partners's 13F filing for Q2 2024, filed 14 Aug 2024.